Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 3
1989 2
1990 2
1991 7
1992 2
1993 7
1994 3
1995 7
1996 3
1997 3
1998 5
1999 4
2000 3
2001 1
2002 6
2003 4
2004 3
2005 3
2006 3
2007 3
2008 3
2010 3
2011 4
2012 1
2013 4
2014 5
2015 1
2016 1
2018 1
2019 4
2020 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

104 results
Results by year
Filters applied: . Clear all
Page 1
Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials).
Crawford J, Prado CM, Johnston MA, Gralla RJ, Taylor RP, Hancock ML, Dalton JT. Crawford J, et al. Among authors: hancock ml. Curr Oncol Rep. 2016 Jun;18(6):37. doi: 10.1007/s11912-016-0522-0. Curr Oncol Rep. 2016. PMID: 27138015 Free PMC article. Review.
Nanoceria distribution and effects are mouse-strain dependent.
Yokel RA, Tseng MT, Butterfield DA, Hancock ML, Grulke EA, Unrine JM, Stromberg AJ, Dozier AK, Graham UM. Yokel RA, et al. Among authors: hancock ml. Nanotoxicology. 2020 Aug;14(6):827-846. doi: 10.1080/17435390.2020.1770887. Epub 2020 Jun 18. Nanotoxicology. 2020. PMID: 32552239 Free PMC article.
104 results